Cyber security, data loss, hacking and schemes to steal personal information and assets electronically are all over the news daily. Companies are the primary targets of these actions since they accumulate information, store...more
In a recent Securities & Exchange Commission (“SEC”) investigation, the SEC interviewed three persons who had proffer agreements with the SEC and United States Attorney. In a subsequent SEC enforcement action, a defendant...more
Dr. Harkonen was the CEO of InterMune, Inc, a pharmaceutical company that developed, marketed and sold drugs for lung and liver diseases, including Actimmune. In 2002, the FDA had approved Actimmune to treat only two...more
2/20/2013
/ Criminal Prosecution ,
Cruel & Unusual Punishment ,
Department of Health and Human Services (HHS) ,
Double Jeopardy ,
Eighth Amendment ,
False Press Release ,
Fifth Amendment ,
Food and Drug Administration (FDA) ,
Misbranding ,
Pharmaceutical Industry ,
Prescription Drugs
At last! We now have official guidance in one place from the United States Department of Justice and the Securities and Exchange Commission regarding the Foreign Corrupt Practices Act (“FCPA”). A lengthy memorandum was...more